1 |
Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, et al. Procalcitonin to reduce long-term infection-associated adverse events in sepsis. A randomized trial [J]. Am J Respir Crit Care Med, 2021, 203(2): 202-210.
|
2 |
Melly L, Torregrossa G, Lee T, et al. Fifty years of coronary artery bypass grafting [J]. J Thorac Dis, 2018, 10(3): 1960-1967.
|
3 |
Coca-Martinez M, Lopez-Hernandez A, Montane-Muntane M, et al. Multimodal prehabilitation as strategy for reduction of postoperative complications after cardiac surgery: a randomised controlled trial protocol [J]. BMJ Open, 2020, 10(12): e39885.
|
4 |
Hulzebos EH, van Meeteren NL. Making the elderly fit for surgery [J]. Br J Surg, 2016, 103(4): 463.
|
5 |
Ahmed AN, Blonde K, Hackam D et al. Prognostic significance of elevated troponin in non-cardiac hospitalized patients: a systematic review and meta-analysis [J]. Ann Med, 2014, 46(8): 653-663.
|
6 |
van der Linden N, Klinkenberg LJJ, Bekers O, et al. Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: A meta-analysis [J]. Medicine (Baltimore), 2016, 95(52): e5703.
|
7 |
Tveit SH, Myhre PL, Hoff NJS, et al. Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study [J]. Clin Biochem, 2020, 78: 10-17.
|
8 |
Zaninotto M, Padoan A, Mion MM et al. Short-term biological variation and diurnal rhythm of cardiac troponin I (Access hs-TnI) in healthy subjects [J]. Clin Chim Acta, 2020, 504: 163-167.
|
9 |
Rehm M, Buchele G, Peter RS, et al. Relationship between cardiac biomarker concentrations and long-term mortality in subjects with osteoarthritis [J]. PLoS One, 2020, 15( 12):e242814.
|
10 |
Rehm M, Buchele G, Brenner RE, et al. Repeated Measurements of Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Assess Long-Term Mortality Risk in Subjects with Osteoarthritis [J]. Biomolecules, 2021, 11(2).
|
11 |
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization [J]. Eur Heart J, 2019, 40(2):87-165.
|
12 |
Doenst T, Haverich A, Serruys P et al. PCI and CABG for treating stable coronary artery disease: JACC review topic of the week [J]. J Am Coll Cardiol, 2019, 73(8): 964-976.
|
13 |
McNeely C, Markwell S, Vassileva C. Trends in patient characteristics and outcomes of coronary artery bypass grafting in the 2000 to 2012 medicare population [J]. Ann Thorac Surg, 2016, 102(1): 132-138.
|
14 |
Head SJ, Milojevic M, Taggart DP et al. Current practice of state-of-the-art surgical coronary revascularization [J]. Circulation, 2017, 136(14): 1331-1345.
|
15 |
Zhao Q, Liu J, Ye XF et al. [Surgical strategies and long-term outcomes of total arterial coronary artery bypass grafting: a series of 208 patients] [J]. Zhonghua Wai Ke Za Zhi, 2020, 58(5): 356-362.
|
16 |
Wettersten N, Horiuchi Y, Maisel A. Advancements in biomarkers for cardiovascular disease: diagnosis, prognosis, and therapy [J]. Fac Rev, 2021, 10: 34.
|
17 |
Wang XY, Zhang F, Zhang C, et al. The biomarkers for acute myocardial infarction and heart failure [J]. Biomed Res Int, 2020, 2020: 2018035.
|
18 |
Jia X, Sun W, Hoogeveen RC, et al. High-sensitivity troponin I and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study [J]. Circulation, 2019, 139(23): 2642-2653.
|
19 |
Roffi M, Patrono C, Collet JP et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2016, 37(3): 267-315.
|
20 |
Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [J]. Eur Heart J, 2021, 42(14): 1289-1367.
|
21 |
Yan I, Börschel CS, Neumann JT, et al. High-sensitivity cardiac troponin I levels and prediction of heart failure: Results from the BiomarCaRE consortium [J]. JACC Heart Fail, 2020, 8(5): 401-411.
|
22 |
Jia X, Sun W, Hoogeveen RC, et al. High-sensitivity troponin I and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study [J]. Circulation, 2019, 139(23): 2642-2653.
|